• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测甲状腺部分或全切除术后甲状腺乳头状癌疾病特异性区域复发和远处复发的列线图。

Nomograms predicting disease-specific regional recurrence and distant recurrence of papillary thyroid carcinoma following partial or total thyroidectomy.

作者信息

Ge Ming-Hua, Cao Jun, Wang Jin-Yu, Huang Yu-Qing, Lan Xia-Bin, Yu Bin, Wen Qing-Liang, Cai Xiu-Jun

机构信息

College of Medicine, Zhejiang University Department of Head and Neck Surgery Medical Record Department, Zhejiang Cancer Hospital Zhejiang Chinese Medical University Department of General Surgery, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.

出版信息

Medicine (Baltimore). 2017 Jul;96(30):e7575. doi: 10.1097/MD.0000000000007575.

DOI:10.1097/MD.0000000000007575
PMID:28746205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5627831/
Abstract

The study aimed to establish effective nomograms for prediction of tumor regional recurrence and distant recurrence of papillary thyroid carcinoma (PTC) patients after partial or total thyroidectomy.These nomograms were based on a retrospective study on 1034 patients who underwent partial or total thyroidectomy for PTC. The predictive accuracy and discriminative ability of the nomograms were evaluated by the concordance index (C-index) and calibration curve. In addition, a validation cohort was included at the same institution.Multivariate analysis demonstrated that family history, maximal tumor diameter, capsular invasion, and lymph node staging were independent risk factors for regional recurrence-free survival; and family history, histological variants, capsular invasion, perineuronal invasion, and vascular invasion were independent risk factors for distant recurrence-free survival. They were selected into the 2 nomograms, respectively, and the C-index for regional recurrence-free survival and distant recurrence-free survival prediction were 0.72 and 0.83, respectively. In the validation cohort, the 2 nomograms displayed a C-index of 0.72 and 0.89, respectively.The nomograms developed in this study demonstrated their discrimination capability for predicting 3 and 5-year regional recurrence and distant recurrence after partial or total thyroidectomy, and can be used to identify high-risk patients.

摘要

本研究旨在建立有效的列线图,以预测甲状腺乳头状癌(PTC)患者在部分或全甲状腺切除术后的肿瘤区域复发和远处复发。这些列线图基于对1034例行PTC部分或全甲状腺切除术患者的回顾性研究。通过一致性指数(C指数)和校准曲线评估列线图的预测准确性和判别能力。此外,在同一机构纳入了一个验证队列。多因素分析表明,家族史、最大肿瘤直径、包膜侵犯和淋巴结分期是区域无复发生存的独立危险因素;家族史、组织学变异、包膜侵犯、神经周侵犯和血管侵犯是远处无复发生存的独立危险因素。它们分别被纳入2个列线图,区域无复发生存和远处无复发生存预测的C指数分别为0.72和0.83。在验证队列中,这2个列线图的C指数分别为0.72和0.89。本研究开发的列线图显示了其对部分或全甲状腺切除术后3年和5年区域复发和远处复发的判别能力,可用于识别高危患者。

相似文献

1
Nomograms predicting disease-specific regional recurrence and distant recurrence of papillary thyroid carcinoma following partial or total thyroidectomy.预测甲状腺部分或全切除术后甲状腺乳头状癌疾病特异性区域复发和远处复发的列线图。
Medicine (Baltimore). 2017 Jul;96(30):e7575. doi: 10.1097/MD.0000000000007575.
2
Validation and Comparison of Nomograms in Predicting Disease-Specific Survival for Papillary Thyroid Carcinoma.预测甲状腺乳头状癌疾病特异性生存的列线图的验证与比较
World J Surg. 2015 Aug;39(8):1951-8. doi: 10.1007/s00268-015-3044-2.
3
Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.双侧预防性中央区颈淋巴结清扫术后甲状腺乳头状癌的隐匿性淋巴结转移及区域复发风险:一项多机构研究
Surgery. 2017 Feb;161(2):465-471. doi: 10.1016/j.surg.2016.07.031. Epub 2016 Aug 26.
4
Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.伴淋巴结转移的甲状腺乳头状癌术后复发
J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967. Epub 2015 Jul 15.
5
Clinicopathological features of recurrent papillary thyroid cancer.复发性甲状腺乳头状癌的临床病理特征
Diagn Pathol. 2015 Jul 14;10:96. doi: 10.1186/s13000-015-0346-5.
6
The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.淋巴结中癌结节的存在是甲状腺乳头状癌患者远处转移和预后不良的一个新指标。
J Cancer Res Clin Oncol. 2017 Jun;143(6):1035-1042. doi: 10.1007/s00432-017-2345-2. Epub 2017 Feb 15.
7
Papillary thyroid carcinoma recurring as squamous cell carcinoma 10 years after total thyroidectomy: lessons from rapidly progressive papillary thyroid carcinoma.甲状腺全切除术后10年复发为鳞状细胞癌的乳头状甲状腺癌:快速进展性乳头状甲状腺癌的经验教训
Intern Med. 2013;52(14):1593-7. doi: 10.2169/internalmedicine.52.9310. Epub 2013 Jul 15.
8
Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.高细胞甲状腺乳头状癌患者复发和死亡的相关风险因素:一项具有预测列线图的单机构队列研究。
JAMA Otolaryngol Head Neck Surg. 2023 Jan 1;149(1):79-86. doi: 10.1001/jamaoto.2022.3781.
9
Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.对于甲状腺乳头状癌,在全甲状腺切除术中常规进行中央区淋巴结清扫可能会将Ⅵ区复发风险降至最低。
Surgery. 2016 Oct;160(4):1049-1058. doi: 10.1016/j.surg.2016.06.042. Epub 2016 Aug 9.
10
Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?甲状腺乳头状癌的T1亚分类与复发风险相关吗?
Langenbecks Arch Surg. 2016 Mar;401(2):223-30. doi: 10.1007/s00423-016-1399-y. Epub 2016 Mar 8.

引用本文的文献

1
The Naples Prognostic Score Exerts a Significant Impact on the Prognosis of Patients Diagnosed with External Auditory Canal Carcinoma After Surgery.那不勒斯预后评分对手术治疗的外耳道癌患者的预后有显著影响。
Cancer Manag Res. 2025 May 25;17:985-996. doi: 10.2147/CMAR.S527496. eCollection 2025.
2
CircTIAM1 overexpression promotes the progression of papillary thyroid cancer by regulating the miR-338-3p/LASP1 axis.环状 RNA TIAM1 通过调控 miR-338-3p/LASP1 轴促进甲状腺乳头状癌细胞的进展。
Oncol Res. 2024 Oct 16;32(11):1747-1763. doi: 10.32604/or.2024.030945. eCollection 2024.
3
FBXO2 promotes the progression of papillary thyroid carcinoma through the p53 pathway.

本文引用的文献

1
Postoperative nomogram for predicting disease-specific death and recurrence in papillary thyroid carcinoma.用于预测甲状腺乳头状癌疾病特异性死亡和复发的术后列线图。
Head Neck. 2016 Apr;38 Suppl 1:E1256-63. doi: 10.1002/hed.24201. Epub 2015 Sep 2.
2
Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.家族性甲状腺乳头状癌的临床病理特征与预后——一项大规模、配对病例对照研究
Clin Endocrinol (Oxf). 2016 Apr;84(4):598-606. doi: 10.1111/cen.12859. Epub 2015 Aug 11.
3
Validation and Comparison of Nomograms in Predicting Disease-Specific Survival for Papillary Thyroid Carcinoma.
FBXO2 通过 p53 通路促进甲状腺乳头状癌的进展。
Sci Rep. 2024 Sep 29;14(1):22574. doi: 10.1038/s41598-024-73455-z.
4
CircNRCAM up-regulates NRCAM to promote papillary thyroid carcinoma progression.环状 RNA NRCAM 通过上调 NRCAM 促进甲状腺乳头状癌的进展。
J Endocrinol Invest. 2024 May;47(5):1215-1226. doi: 10.1007/s40618-023-02241-x. Epub 2024 Mar 14.
5
Emerging roles of circular RNAs in the invasion and metastasis of head and neck cancer: Possible functions and mechanisms.环状RNA在头颈癌侵袭和转移中的新作用:可能的功能及机制
Cancer Innov. 2023 Feb 19;2(6):463-487. doi: 10.1002/cai2.50. eCollection 2023 Dec.
6
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM.基于新的 ATA 风险分类和 TNM,对连续前瞻性分化型甲状腺癌系列进行前瞻性研究并提出预后预测列线图
Front Endocrinol (Lausanne). 2023 Mar 13;14:1128963. doi: 10.3389/fendo.2023.1128963. eCollection 2023.
7
Identification of m6A-related lncRNAs for thyroid cancer recurrence.用于甲状腺癌复发的m6A相关长链非编码RNA的鉴定
Gland Surg. 2023 Jan 1;12(1):39-53. doi: 10.21037/gs-22-678. Epub 2023 Jan 6.
8
Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review.甲状腺乳头状癌预后列线图的准确性:一项系统评价。
Endocr Connect. 2023 Mar 10;12(4). doi: 10.1530/EC-22-0457. Print 2023 Apr 1.
9
Circular RNA hsa_circ_0003892 promotes the development of papillary thyroid carcinoma by regulating the miR-326/LASP1 axis.环状RNA hsa_circ_0003892通过调控miR-326/LASP1轴促进甲状腺乳头状癌的发展。
Histol Histopathol. 2023 May;38(5):585-595. doi: 10.14670/HH-18-546. Epub 2022 Nov 17.
10
Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression.晚期糖基化终产物及其他晚期糖基化终产物受体配体在甲状腺癌进展中的作用
J Clin Med. 2021 Sep 10;10(18):4084. doi: 10.3390/jcm10184084.
预测甲状腺乳头状癌疾病特异性生存的列线图的验证与比较
World J Surg. 2015 Aug;39(8):1951-8. doi: 10.1007/s00268-015-3044-2.
4
Recurrence of papillary thyroid cancer after optimized surgery.优化手术后甲状腺乳头状癌的复发
Gland Surg. 2015 Feb;4(1):52-62. doi: 10.3978/j.issn.2227-684X.2014.12.06.
5
Radioactive iodine treatment for node negative papillary thyroid cancer with capsular invasion only: Results of a large retrospective study.仅伴有包膜侵犯的淋巴结阴性乳头状甲状腺癌的放射性碘治疗:一项大型回顾性研究的结果
Asia Pac J Clin Oncol. 2016 Mar;12(1):e167-73. doi: 10.1111/ajco.12159. Epub 2013 Dec 2.
6
Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour.家族性与散发性甲状腺乳头状癌:一项匹配病例对照研究显示出相似的临床/预后行为。
Eur J Endocrinol. 2013 Dec 21;170(2):321-7. doi: 10.1530/EJE-13-0865. Print 2014 Feb.
7
Prognostic nomograms to predict oncological outcome of thyroid cancers.预测甲状腺癌肿瘤学结局的预后列线图。
J Clin Endocrinol Metab. 2013 Dec;98(12):4768-75. doi: 10.1210/jc.2013-2318. Epub 2013 Oct 23.
8
Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.家族性非髓样甲状腺癌病史是年轻常规型乳头状甲状腺癌患者肿瘤复发的独立预后因素。
J Surg Oncol. 2014 Feb;109(2):168-73. doi: 10.1002/jso.23447. Epub 2013 Oct 16.
9
Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome.疾病甲状腺外延伸程度对甲状腺乳头状癌结局的影响。
Thyroid. 2014 Feb;24(2):241-4. doi: 10.1089/thy.2012.0567. Epub 2013 Sep 3.
10
Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer.基于人群的研究评估和预测甲状腺癌患者因甲状腺癌和其他原因导致死亡的概率。
J Clin Oncol. 2013 Feb 1;31(4):468-74. doi: 10.1200/JCO.2012.42.4457. Epub 2012 Dec 26.